Baker / Tisch Capital (GP), LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker / Tisch Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker / Tisch Capital (GP), LLC. Baker / Tisch Capital (GP), LLC is Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in SEATTLE GENETICS INC /WA ($SGEN) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Latest Insider Trading Transactions of Baker / Tisch Capital (GP), LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, AUXL, SGEN, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Option Exercise | X | 6.25 | 49,563 | 309,769 | 0 | |
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker / Tisch Capital (GP), LL ... | Director | Buy | X | 6.25 | 49,563 | 309,769 | 450,461 | 400.9 K to 450.5 K (+12.36 %) |
| Jan 03 2012 | ADLR | ADOLOR CORP | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | U | 4.25 | 12,679 | 53,886 | 0 | 12.7 K to 0 (-100.00 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Grant | A | 0.00 | 55,187 | 0 | 206,800 | 151.6 K to 206.8 K (+36.40 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Grant | A | 0.00 | 53,754 | 0 | 151,613 | 97.9 K to 151.6 K (+54.93 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Grant | A | 0.00 | 56,954 | 0 | 97,859 | 40.9 K to 97.9 K (+139.23 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker / Tisch Capital (GP), LL ... | Director | Grant | A | 0.00 | 8,821 | 0 | 40,905 | 32.1 K to 40.9 K (+27.49 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 17.25 | 507 | 8,745 | 67,322 | 67.8 K to 67.3 K (-0.75 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 18.04 | 4,902 | 88,427 | 67,829 | 72.7 K to 67.8 K (-6.74 %) |
| Aug 03 2011 | AUXL | AUXILIUM PHARMACEU ... | Baker / Tisch Capital (GP), LL ... | 10% Owner | Sell | S | 18.03 | 3,243 | 58,470 | 72,731 | 76 K to 72.7 K (-4.27 %) |
Page: 1